[go: up one dir, main page]

AU2003208858A1 - USE OF MIP-3Alpha AND ITS RECEPTOR TO TREAT ARTHRITIS - Google Patents

USE OF MIP-3Alpha AND ITS RECEPTOR TO TREAT ARTHRITIS

Info

Publication number
AU2003208858A1
AU2003208858A1 AU2003208858A AU2003208858A AU2003208858A1 AU 2003208858 A1 AU2003208858 A1 AU 2003208858A1 AU 2003208858 A AU2003208858 A AU 2003208858A AU 2003208858 A AU2003208858 A AU 2003208858A AU 2003208858 A1 AU2003208858 A1 AU 2003208858A1
Authority
AU
Australia
Prior art keywords
3alpha
mip
receptor
treat arthritis
arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003208858A
Other versions
AU2003208858A8 (en
Inventor
Chandrika Saidapet Kumar
Mark Aron Labow
Brian Jude Latario
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2003208858A1 publication Critical patent/AU2003208858A1/en
Publication of AU2003208858A8 publication Critical patent/AU2003208858A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003208858A 2002-02-15 2003-02-14 USE OF MIP-3Alpha AND ITS RECEPTOR TO TREAT ARTHRITIS Abandoned AU2003208858A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35758802P 2002-02-15 2002-02-15
US60/357,588 2002-02-15
PCT/EP2003/001506 WO2003069348A2 (en) 2002-02-15 2003-02-14 USE OF MIP-3α AND ITS RECEPTOR TO TREAT ARTHRITIS

Publications (2)

Publication Number Publication Date
AU2003208858A1 true AU2003208858A1 (en) 2003-09-04
AU2003208858A8 AU2003208858A8 (en) 2003-09-04

Family

ID=27734758

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003208858A Abandoned AU2003208858A1 (en) 2002-02-15 2003-02-14 USE OF MIP-3Alpha AND ITS RECEPTOR TO TREAT ARTHRITIS

Country Status (2)

Country Link
AU (1) AU2003208858A1 (en)
WO (1) WO2003069348A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009096716A (en) * 2006-01-19 2009-05-07 Eisai R & D Management Co Ltd Treatment of autoimmune disease by anti-ccl20 antibody
US20090304704A1 (en) * 2006-05-03 2009-12-10 Geisinger Clinic Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash)
WO2012006056A2 (en) * 2010-06-29 2012-01-12 Oregon Health & Science University Ccr6 as a biomarker of alzheimer's disease
CN118556073A (en) * 2021-10-06 2024-08-27 维罗治疗有限公司 Novel immunomodulator

Also Published As

Publication number Publication date
WO2003069348A2 (en) 2003-08-21
WO2003069348A3 (en) 2004-07-29
AU2003208858A8 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
IL166280A0 (en) Treatment of TNF? related disorders
AU2003239568A1 (en) Pyrrolotriazinone compounds and their use to treat diseases
IL164295A0 (en) Tri-substituted heteroaryls and methods of making and using the same
EP1474445A4 (en) Glycoisoforms of adiponectin and uses thereof
AU2003295336A1 (en) Use of etodoclac to treat hyperplasia
AU2003279841A8 (en) Uses of human zven antagonists
GB0212405D0 (en) Composition and its therapeutic use
GB0207410D0 (en) Compounds and their therapeutic use
AU2003208858A1 (en) USE OF MIP-3Alpha AND ITS RECEPTOR TO TREAT ARTHRITIS
AU2003220201A1 (en) Purification and cloning of nmn adenylyltranserase and its therapeutic use
EP1534293A4 (en) Anti-inflammatory compositions and methods of use
AU2003285686A8 (en) Glycoisoforms of adiponectin and uses thereof
AU2003296871A8 (en) Point feeder and use of point feeder
AU2003264297A1 (en) Use of vanilloid receptor antagonists for the treatment of pain
AU2003283938A1 (en) Use of certain compounds in treatment of obesity
AU2003267465A1 (en) Shower and hydromassage device
AU2003231353A1 (en) Healthcare massage and bathing system
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
AU2003240446A1 (en) Use of mob-5 in pain
GB0205395D0 (en) Materials and methods relating to the treatment of lymphoma
IL164099A0 (en) Use of interleukin-19 to treat cervical cancer
GB0229986D0 (en) Treatment of materials
AU2003293714A1 (en) Methods for the treatment of chronic pain and compositions therefor
TW561877U (en) Improved structure of spine fastening device
TW583979U (en) Structure of massage bar

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase